Status:
COMPLETED
Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Peritoneal Dialysis Associated Peritonitis
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Peritoneal dialysis (PD) is the first-line treatment of end stage renal disease (ESRD) in Hong Kong. Despite the advances in antibiotic therapy and connecting system, recurrent peritonitis remains the...
Eligibility Criteria
Inclusion
- at least two of the followings:
- abdominal pain or cloudy PD effluent;
- leukocytosis in PD effluent (WBC \> 100/ml); and
- positive Gram-stain or culture from PD effluent
Exclusion
- mycobacterial peritonitis
- obvious surgical problems and require laparotomy
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
325 Patients enrolled
Trial Details
Trial ID
NCT01817309
Start Date
June 1 2013
End Date
April 1 2015
Last Update
July 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine, Prince of Wales Hospital
Shatin, Hong Kong